rare diseasesSynaptixBio Ltd gets FDA ODD for leukodystrophyLatest NewsRare disease specialist SynaptixBio Ltd has got its second FDA orphan drug designation for a subtype of TUBB4A leukodystrophy. Read more 5 March 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/leukodystrophy.png 1232 2482 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-03-05 15:34:272024-06-13 14:26:24SynaptixBio Ltd gets FDA ODD for leukodystrophy